297 related articles for article (PubMed ID: 8784229)
1. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies.
Morris ED; Alpert NM; Fischman AJ
J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229
[TBL] [Abstract][Full Text] [Related]
2. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection.
Buck A; Mulholland GK; Papadopoulos SM; Koeppe RA; Frey KA
J Cereb Blood Flow Metab; 1996 Nov; 16(6):1280-7. PubMed ID: 8898702
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach.
Delforge J; Bottlaender M; Loc'h C; Guenther I; Fuseau C; Bendriem B; Syrota A; Mazière B
J Cereb Blood Flow Metab; 1999 May; 19(5):533-46. PubMed ID: 10326721
[TBL] [Abstract][Full Text] [Related]
4. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T
J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875
[TBL] [Abstract][Full Text] [Related]
5. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
[TBL] [Abstract][Full Text] [Related]
6. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding.
Zubieta JK; Koeppe RA; Mulholland GK; Kuhl DE; Frey KA
J Cereb Blood Flow Metab; 1998 Jun; 18(6):619-31. PubMed ID: 9626186
[TBL] [Abstract][Full Text] [Related]
7. Distribution volume ratios without blood sampling from graphical analysis of PET data.
Logan J; Fowler JS; Volkow ND; Wang GJ; Ding YS; Alexoff DL
J Cereb Blood Flow Metab; 1996 Sep; 16(5):834-40. PubMed ID: 8784228
[TBL] [Abstract][Full Text] [Related]
8. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches.
Delforge J; Syrota A; Bottlaender M; Varastet M; Loc'h C; Bendriem B; Crouzel C; Brouillet E; Maziere M
J Cereb Blood Flow Metab; 1993 May; 13(3):454-68. PubMed ID: 8478404
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
[TBL] [Abstract][Full Text] [Related]
10. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
[TBL] [Abstract][Full Text] [Related]
11. Concept of reaction volume in the in vivo ligand-receptor model.
Delforge J; Syrota A; Bendriem B
J Nucl Med; 1996 Jan; 37(1):118-25. PubMed ID: 8543980
[TBL] [Abstract][Full Text] [Related]
12. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
Morris ED; Babich JW; Alpert NM; Bonab AA; Livni E; Weise S; Hsu H; Christian BT; Madras BK; Fischman AJ
Synapse; 1996 Nov; 24(3):262-72. PubMed ID: 8923667
[TBL] [Abstract][Full Text] [Related]
13. Simplified reference tissue model for PET receptor studies.
Lammertsma AA; Hume SP
Neuroimage; 1996 Dec; 4(3 Pt 1):153-8. PubMed ID: 9345505
[TBL] [Abstract][Full Text] [Related]
14. Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data.
Delforge J; Syrota A; Mazoyer BM
IEEE Trans Biomed Eng; 1990 Jul; 37(7):653-61. PubMed ID: 2394453
[TBL] [Abstract][Full Text] [Related]
15. Absolute quantification by positron emission tomography of the endogenous ligand.
Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of potential new and selective PET radiotracers for the serotonin transporter. Positron Emission Tomography.
Wellsow J; Kovar KA; Machulla HJ
J Pharm Pharm Sci; 2002; 5(3):245-57. PubMed ID: 12553893
[TBL] [Abstract][Full Text] [Related]
17. The quantitative analysis of D2-dopamine receptors in baboon striatum in vivo with 3-N-[2'-18F]fluoroethylspiperone using positron emission tomography.
Jovkar S; Wienhard K; Pawlik G; Coenen HH
J Cereb Blood Flow Metab; 1990 Sep; 10(5):720-6. PubMed ID: 2384543
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.
Lassen NA; Bartenstein PA; Lammertsma AA; Prevett MC; Turton DR; Luthra SK; Osman S; Bloomfield PM; Jones T; Patsalos PN
J Cereb Blood Flow Metab; 1995 Jan; 15(1):152-65. PubMed ID: 7798333
[TBL] [Abstract][Full Text] [Related]
19. Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers.
Lassen NA
J Cereb Blood Flow Metab; 1992 Sep; 12(5):709-16. PubMed ID: 1506439
[TBL] [Abstract][Full Text] [Related]
20. In vivo receptor assay with multiple ligand concentrations: an equilibrium approach.
Holden JE; Jivan S; Ruth TJ; Doudet DJ
J Cereb Blood Flow Metab; 2002 Sep; 22(9):1132-41. PubMed ID: 12218419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
